Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort. lancet hiv • June 1, 2020June 2, 2020
Effect of the CCR5 antagonist maraviroc on the occurrence of immune reconstitution inflammatory syndrome in HIV (CADIRIS): a double-blind, randomised, placebo-controlled trial. lancet hiv • October 2, 2015
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of a Chemokine Receptor 5 (CCR5) Antagonist to Decrease the Occurrence of Immune Reconstitution Inflammatory Syndrome in HIV-Infection: The CADIRIS Study. lancet hiv • September 15, 2015